Essential thrombocythemia is a chronic condition with excessive platelet production, increasing thrombosis risk, and is often linked to JAK2, CALR, or MPL mutations. Stage 1 ET is manageable with ...
Essential thrombocythemia is a myeloproliferative neoplasm with excessive platelet production, potentially causing clotting or bleeding issues. Diagnosis involves blood tests, genetic testing, and ...
"These patients [with extreme thrombocytosis] had improved overall survival and lower bleeding risk compared to those with normal or low platelet counts at the time of diagnosis." — Marko Lucijanic, ...
Zacks Small Cap Research on MSN
CVKD acquires 12-LOX inhibitor for the treatment of heparin-induced thrombocytopenia (HIT)
By David Bautz, PhD NASDAQ:CVKD READ THE FULL CVKD RESEARCH REPORT Business Update Acquires 12-LOX Inhibitor VLX-1005 for the Treatment of HIT In December 2025, Cadrenal Therapeutics, Inc.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results